ImpediMed Ltd Sustainability Reports
ImpediMed Limited develops and distributes non-invasive medical devices that utilize bioimpedance spectroscopy technology. Its products are primarily used by healthcare clinicians to measure, monitor, and manage fluid status and tissue composition data in chronic diseases like lymphedema and heart failure.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 254900I3YH2IS1UEHJ67
FIGI: BBG001SR4J92
14 reports from 2008 to 2025
